WCN26-1661 ASSOCIATIONS BETWEEN CARDIOVASCULAR HEALTH, END-STAGE KIDNEY DISEASE, AND SYSTEMIC INFLAMMATION: EVIDENCE FROM THE PROSPECTIVE UK BIOBANK COHORT

Read full text Summarise with VIRAT
Authors: Chenxinan Ma, Mihir Gandhi, Tazeen H. Jafar
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Promoting cardiovascular health (CVH) has been proposed as a primordial prevention strategy to address the cardiovascular-kidney-metabolic (CKM) syndrome. However, most evidence to date has focused on cardiovascular disease with limited understanding of how CVH relates to the progression to end-stage kidney disease (ESKD). Systemic inflammation, a driver of chronic kidney disease (CKD) progression, has emerged as a potential therapeutic target as higher inflammatory burden is linked to greater ESKD risk.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Dialysis and Renal Disease Management Cardiovascular Health and Risk Factors

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104679–104679
Publication date
25 March 2026
Language
EN